New combo may speed stem cell harvest for myeloma patients
NCT ID NCT05087212
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a combination of two drugs, plerixafor and G-CSF, to help collect stem cells from the blood of 53 people with multiple myeloma. The goal was to see if this approach could gather enough healthy stem cells for a transplant in fewer sessions. Results showed the combination was effective and safe for most participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
plerixafor and G-CSF (drug combination)
What this could lead to
If successful, this combination could make stem cell collection faster and more reliable for multiple myeloma patients needing a transplant.
What could go wrong
This is a small, single-group study (53 people) with no comparison group, so results may not apply to all patients. The treatment is for stem cell collection, not a cure for myeloma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Sites
China, China